Valuation (90%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.36 | N/A |
| PEG Ratio (TTM) | 0.67 | N/A |
| P/S Ratio (TTM) | 0.12 | N/A |
| P/B Ratio (TTM) | 1.03 | N/A |
| P/FCF Ratio (TTM) | 7.65 | N/A |
| Price to 5YR AVG Earnings Ratio | 19.75 | N/A |
| Price to 5YR AVG FCF Ratio | 9.62 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.55% | N/A |
| ROE (TTM) | 8.53% | N/A |
| Net Profit Margin (TTM) | 1.06% | N/A |
| ROIC 5YR AVG | 6.84% | N/A |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 217.31% | 199.51% | 118.62% |
| Revenue | -7.61% | 74.13% | 48.98% |
| Net Income | 214.71% | 199.34% | 120.25% |
| Cash Flow | -29.49% | 330.47% | 376.71% |
Health (70%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.98 | N/A |
| Quick Ratio (TTM) | 1.23 | N/A |
| D/E Ratio (TTM) | 0.44 | N/A |
| Interest Coverage (TTM) | 7.28 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 4.76 | N/A |
| LTL to 5YR AVG FCF | 4.19 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.78% | N/A |